Mutations of APC, TP53 and KRAS have been proposed as a genetic model, which drives the transition from healthy colonic epithelia to CRC through increasingly dysplastic adenoma, and these mutations lie on alternate pathways of CRC development. The gene discussed is KRAS; the disease is colorectal carcinoma.